1. KerchnerGA BoxerAL(2010)Bapineuzumab. Expert Opin Biol Ther10(7):1121‐1130.https://doi.org/10.1517/14712598.2020.493872
2. ColeyN AndrieuS DelrieuJ VoisinT VellasB(2009)Biomarkers in Alzheimer’s disease: not yet surrogate endpoints. Annals of the New York Academy of Sciences1180(1):119‐124.https://doi.org/10.1111/j.1749‐6632.2009.04947.x
3. FoxNC BlackRS GilmanS LRossorMN GriffithSG JenkinsL KollerM(2005)AN1792 (QS‐21)‐201 Study. Effects of Abeta immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease. Neurology (2005)64(9):1563‐1572.https://doi.org/10.1212/01.WNL.0000159743.08996.00
4. SchenkD(2002)Amyloid‐β immunotherapy for Alzheimer’s disease: the end of the beginning. Nature Reviews3:824‐828.https://doi.org/10.1038/nrn938